Encompass Health Corp. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

1,586.60

1,544.60

1,477.50

1,457.70

1,455.40

1,405.00

1,351.00

Other Operating Income

0.00

Total Operating income

1,586.60

1,544.60

1,477.50

1,457.70

1,455.40

1,405.00

1,351.00

Raw Material Cost

1,226.80

1,192.80

1,177.80

1,139.20

1,136.10

1,118.20

1,087.90

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

818.10

801.10

784.80

767.70

762.30

756.80

732.10

Power Cost

0.00

Manufacturing Expenses

31.80

30.20

30.80

30.40

31.80

33.00

34.90

Selling and Distribution Expenses

58.20

68.40

56.10

59.40

52.30

54.50

54.00

Other Expenses

-84.99

-83.13

-81.56

-79.81

-79.41

-78.98

-76.70

Total Expenditure (Excl Depreciation)

1,285.00

1,261.20

1,233.90

1,198.60

1,188.40

1,172.70

1,141.90

Operating Profit (PBDIT) excl Other Income

301.6

283.4

243.6

259.1

267

232.3

209.1

Other Income

19.30

4.50

7.10

8.10

3.40

2.30

10.00

Operating Profit (PBDIT)

408.20

374.30

333.10

347.10

349.60

312.60

297.50

Interest

31.80

30.20

30.80

30.40

31.80

33.00

34.90

Exceptional Items

-0.40

0.00

-0.20

-0.40

Gross Profit (PBDT)

359.80

351.80

299.70

318.50

319.30

286.80

263.10

Depreciation

87.30

86.40

82.40

79.90

79.20

78.00

78.40

Profit Before Tax

288.70

257.70

219.90

236.80

238.60

201.40

183.80

Tax

56.40

55.40

44.90

51.00

41.60

37.60

36.00

Provisions and contingencies

0.00

Profit After Tax

178.10

144.90

126.60

142.60

151.60

119.70

108.20

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

178.10

144.90

126.60

142.60

151.60

119.70

108.20

Share in Profit of Associates

0.00

Minority Interest

53.70

57.00

48.10

42.80

45.00

43.30

38.90

Other related items

0.00

Consolidated Net Profit

231.80

201.90

174.70

185.40

196.60

163.00

147.10

Equity Capital

0.00

Face Value

0.01

Reserves

2,521.70

2,438.20

2,373.80

2,280.10

2,159.10

2,067.00

1,959.80

Earnings per share (EPS)

1.93

1.43

1.24

1.39

1.48

1.18

1.06

Diluted Earnings per share

1.93

1.43

1.24

1.39

1.48

1.18

1.06

Operating Profit Margin (Excl OI)

19.01%

18.35%

16.49%

17.77%

18.35%

16.53%

15.48%

Gross Profit Margin

23.7%

22.28%

20.46%

21.73%

21.84%

19.89%

19.41%

PAT Margin

11.23%

9.38%

8.57%

9.78%

10.42%

8.52%

8.01%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.72% vs 4.54% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 14.81% vs 15.57% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 5.16% vs 13.44% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 5.30% vs -1.95% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Encompass Health Corp. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

1,586.60

1,420.46

166.14

11.70%

Other Operating Income

0.00

Total Operating income

1,586.60

1,420.46

166.14

11.70%

Raw Material Cost

1,226.80

1,362.23

-135.43

-9.94%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

818.10

0.00

818.10

Power Cost

0.00

Manufacturing Expenses

31.80

1.81

29.99

1,656.91%

Selling and Distribution Expenses

58.20

48.12

10.08

20.95%

Other Expenses

-84.99

-0.18

-84.81

-47,116.67%

Total Expenditure (Excl Depreciation)

1,285.00

1,410.35

-125.35

-8.89%

Operating Profit (PBDIT) excl Other Income

301.60

10.11

291.49

2,883.18%

Other Income

19.30

27.76

-8.46

-30.48%

Operating Profit (PBDIT)

408.20

44.66

363.54

814.02%

Interest

31.80

1.81

29.99

1,656.91%

Exceptional Items

-0.40

-6.11

5.71

93.45%

Gross Profit (PBDT)

359.80

58.23

301.57

517.89%

Depreciation

87.30

6.79

80.51

1,185.71%

Profit Before Tax

288.70

29.94

258.76

864.26%

Tax

56.40

0.03

56.37

187,900.00%

Provisions and contingencies

0.00

Profit After Tax

178.10

29.92

148.18

495.25%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

178.10

29.92

148.18

495.25%

Share in Profit of Associates

0.00

Minority Interest

53.70

0.00

53.70

Other related items

0.00

Consolidated Net Profit

231.80

29.92

201.88

674.73%

Equity Capital

0.00

Face Value

0.01

0.00

Reserves

2,521.70

181.43

2,340.27

1,289.90%

Earnings per share (EPS)

1.93

1.80

0.13

7.22%

Diluted Earnings per share

1.93

1.80

0.13

7.22%

Operating Profit Margin (Excl OI)

19.01%

0.71%

0.00

18.30%

Gross Profit Margin

23.70%

2.59%

0.00

21.11%

PAT Margin

11.23%

2.11%

0.00

9.12%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 158.66 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 2.72% vs 4.54% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 9.01% vs 10.59% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 23.18 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 14.81% vs 15.57% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 17.90% vs 41.13% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 38.89 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 5.16% vs 13.44% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 12.33% vs 24.62% in Mar 2025

Quarterly - Interest

Interest 3.18 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 5.30% vs -1.95% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 0.00% vs -9.66% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.01%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025